Charles Seife, a professor of journalism at New York University, writes about how drug companies are funneling money to prominent scientists who are doing research that affects their products.
This article was published in the December 2012 edition of Scientific American.
Want more Scientific American?
©2012 Scientific American
Report Inappropriate Content